"Israeli Scientists' Mushroom Extract Surpasses Synthetic Psilocybin in Psychiatric Therapy"

A study led by researchers at the Hebrew University of Jerusalem suggests that mushroom extract containing psilocybin may have a more potent and enduring impact on synaptic plasticity compared to chemically synthesized psilocybin. The research, focusing on synaptic plasticity in mice, reveals promising insights into the potential therapeutic benefits of natural psychedelic compounds in addressing psychiatric disorders. The study's findings open up new possibilities for the therapeutic use of natural psychedelic compounds, providing hope for those who have found little relief in conventional psychiatric treatments. Controlled mushroom cultivation offers a promising approach to replicate extracts for medicinal use, highlighting the feasibility of incorporating them into Western medicine.